|
CHMP4C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.23580035094051E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69490000034855E-07 |
| Normal-vs-Stage2 |
2.611800E-04 |
| Normal-vs-Stage3 |
2.10209960549435E-10 |
| Normal-vs-Stage4 |
4.52604620448938E-12 |
| Stage1-vs-Stage2 |
7.989800E-01 |
| Stage1-vs-Stage3 |
8.005400E-04 |
| Stage1-vs-Stage4 |
1.53756999999866E-05 |
| Stage2-vs-Stage3 |
5.075800E-02 |
| Stage2-vs-Stage4 |
7.923100E-03 |
| Stage3-vs-Stage4 |
3.829000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.16311429773941E-12 |
| Normal-vs-AfricanAmerican |
1.220800E-03 |
| Normal-vs-Asian |
3.898000E-01 |
| Caucasian-vs-AfricanAmerican |
6.684400E-02 |
| Caucasian-vs-Asian |
1.153590E-01 |
| AfricanAmerican-vs-Asian |
5.168400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4958000393861E-09 |
| Normal-vs-Female |
7.7063999626148E-10 |
| Male-vs-Female |
9.607600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.762800E-04 |
| Normal-vs-Age(41-60Yrs) |
6.72989997063667E-10 |
| Normal-vs-Age(61-80Yrs) |
3.33090000026459E-09 |
| Normal-vs-Age(81-100Yrs) |
1.601680E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.119200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.018000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.941400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.439800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.694200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.677000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.001200E-01 |
| Normal-vs-Grade 2 |
2.188100E-04 |
| Normal-vs-Grade 3 |
1.6304735339645E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
1.225010E-01 |
| Grade 1-vs-Grade 3 |
2.041200E-04 |
| Grade 1-vs-Grade 4 |
2.28930000001348E-06 |
| Grade 2-vs-Grade 3 |
5.54460000135037E-08 |
| Grade 2-vs-Grade 4 |
1.25249810523087E-11 |
| Grade 3-vs-Grade 4 |
4.003500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.78390000005191E-06 |
| Normal-vs-ccB subtype |
3.26459970168003E-11 |
| ccA subtype-vs-ccB subtype |
2.09839999999462E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.33000002309348E-10 |
| Normal-vs-N1 |
3.245500E-04 |
| N0-vs-N1 |
4.442000E-01 |
|
|
